Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88367584 | FILING DATE | 04/02/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | GLASSER, CARYN |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
RUN DATE | 11/01/2019 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 10/31/2019 | ||
LITERAL MARK ELEMENT | TISSUE-TEK GENIE | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | TISSUE-TEK GENIE |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Sakura Finetek U.S.A., Inc. |
ADDRESS | 1750 West 214th St. Torrance, CA 90501 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | California |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 001 |
DESCRIPTION TEXT | Diagnostic reagents for scientific and research use |
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Diagnostic reagents for medical use |
INTERNATIONAL CLASS | 009 |
DESCRIPTION TEXT | Research and laboratory instruments, namely, fluorescent in situ hybridization instruments and in situ hybridization instruments for use in applying reagents and stains to tissue samples, handling tissue samples, heating or cooling tissue samples and automated immunohisto chemistry |
INTERNATIONAL CLASS | 010 |
DESCRIPTION TEXT | Diagnostic medical laboratory, autopsy and pathology equipment, namely, fluorescent in situ hybridization instruments and in situ hybridization instruments for processing biological samples for subsequent testing or examination for medical purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PSEUDO MARK | TISSUE-TECH GENIE |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
10/31/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 014 |
10/31/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 013 |
10/31/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 012 |
10/31/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 011 |
10/31/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 010 |
10/29/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
10/28/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
10/28/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
06/13/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
06/13/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
06/13/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
06/12/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
04/19/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
04/05/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Alan M. Kindred |
CORRESPONDENCE ADDRESS | Alan M. Kindred LEECH TISHMAN FUSCALDO & LAMPL, INC. 200 S. LOS ROBLES AVE. SUITE 210 PASADENA, CA 91101-2419 |
DOMESTIC REPRESENTATIVE | NONE |